POLITICONew Alzheimer's drug could be 'devastating' for MedicareJun 15, 2021David Lim, Katherine Foley & Rachel RoubeinBy David Lim, Katherine Foley & Rachel Roubeinmore_vert
Medpage TodayOpinion | The FDA Is Failing the American PeopleJun 16, 2021Vinay PrasadBy Vinay Prasadmore_vert
STATQ&A: The CEO of the Alzheimer's Association on the approval of AduhelmJun 16, 2021Andrew JosephBy Andrew Josephmore_vert
The New York TimesOpinion | The F.D.A.'s Approval of Biogen's Alzheimer's Drug Is a New LowJun 15, 2021Aaron Kesselheim & Jerry AvornBy Aaron Kesselheim & Jerry Avornmore_vert
STAT6 ways the FDA's approval of Aduhelm does more harm than goodJun 15, 2021Sam GandyBy Sam Gandymore_vert
Full CoverageFull Coverage